RAMM Pharma Corp. Provides Additional Disclosure in Connection with its Upcoming Special Meeting of Shareholders

TORONTO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM) wishes to supplement the information contained in its management information circular (the “Circular”) dated October 9, 2025 regarding its proposed transaction (the "Transaction”) with The Global South S.A.S (“Global South”) following a review by the Ontario Securities Commission, which Transaction will be subject to the approval of the minority shareholders at the Company’s upcoming Special Meeting of Shareholders (the “Meeting”) scheduled to take place on November 12, 2025 at 2:30 p.m. (Toronto Time). In light of the additional information contained herein, the Company confirms that it is waiving its proxy cut-off time such that it will accept proxy forms up until one hour prior to the commencement of the Meeting.